Skip to main content

Table 2 Characteristics of patients diagnosed with oesophago-gastric cancers in England between 1998 and 2007

From: Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study

 

Upper and middle oesophagus

Lower oesophagus

Oesophagus not otherwise specified

Cardia

Non-cardia

Stomach not otherwise specified

Oesophageal and gastric cancer

 

18,128

35,849

7,898

18,728

15,340

37,861

133,804

Male

8,228

(45.4)

26,495

(73.9)

4,323

(54.7)

14,107

(75.3)

9,531

(62.1)

22,677

(59.9)

85,361

(63.8)

Female

9,900

(54.6)

9,354

(26.1)

3,575

(45.3)

4,621

(24.7)

5,809

(37.9)

15,184

(40.1)

48,443

(36.2)

Death certificate only (DCO)

63

(0.3)

98

(0.3)

1,769

(22.4)

117

(0.6)

51

(0.3)

2,892

(7.6)

4,990

(3.7)

Median age

73

 

72

 

78

 

71

 

75

 

76

 

74

 

< 50

706

(3.9)

1,682

(4.7)

180

(2.3)

1,043

(5.6)

595

(3.9)

1,568

(4.1)

5,774

(4.3)

50-54

937

(5.2)

1,986

(5.5)

227

(2.9)

1,025

(5.5)

384

(2.5)

961

(2.5)

5,520

(4.1)

55-59

1,513

(8.3)

3,149

(8.8)

396

(5.0)

1,626

(8.7)

699

(4.6)

1,671

(4.4)

9,054

(6.8)

60-64

1,864

(10.3)

3,980

(11.1)

552

(7.0)

2,124

(11.3)

1,196

(7.8)

2,646

(7.0)

12,362

(9.2)

65-69

2,320

(12.8)

4,775

(13.3)

707

(9.0)

2,680

(14.3)

2,010

(13.1)

4,326

(11.4)

16,818

(12.6)

70-74

2,851

(15.7)

5,687

(15.9)

1,030

(13.0)

3,162

(16.9)

2,735

(17.8)

6,013

(15.9)

21,478

(16.1)

75-79

3,018

(16.6)

6,170

(17.2)

1,444

(18.3)

3,185

(17.0)

3,056

(19.9)

7,293

(19.3)

24,166

(18.1)

80-84

2,496

(13.8)

4,735

(13.2)

1,364

(17.3)

2,218

(11.8)

2,497

(16.3)

6,585

(17.4)

19,895

(14.9)

85+

2,423

(13.4)

3,685

(10.3)

1,998

(25.3)

1,665

(8.9)

2,168

(14.1)

6,798

(18.0)

18,737

(14.0)

Quintile of deprivation 2007 †

1 = (Affluent)

1,503

(16.1)

3,589

(18.8)

592

(16.6)

1,554

(17.5)

1,058

(15.0)

2,607

(15.3)

10,903

(16.8)

2

1,793

(19.2)

4,133

(21.6)

701

(19.7)

1,855

(20.9)

1,320

(18.7)

3,094

(18.1)

12,896

(19.8)

3

1,980

(21.2)

4,143

(21.7)

741

(20.8)

1,941

(21.8)

1,503

(21.3)

3,409

(20.0)

13,717

(21.1)

4

1,994

(21.4)

4,000

(20.9)

791

(22.2)

1,811

(20.4)

1,625

(23.0)

3,782

(22.2)

14,003

(21.5)

5 = (Deprived)

2,058

(22.1)

3,256

(17.0)

738

(20.7)

1,730

(19.5)

1,561

(22.1)

4,180

(24.5)

13,523

(20.8)

Year of diagnosis

1998

1,702

(9.4)

3,067

(8.6)

929

(11.8)

2,022

(10.8)

1,752

(11.4)

4,446

(11.7)

13,918

(10.4)

1999

1,754

(9.7)

3,191

(8.9)

905

(11.5)

2,020

(10.8)

1,546

(10.1)

4,301

(11.4)

13,717

(10.3)

2000

1,805

(10.0)

3,292

(9.2)

923

(11.7)

2,014

(10.8)

1,669

(10.9)

4,261

(11.3)

13,964

(10.4)

2001

1,751

(9.7)

3,574

(10.0)

810

(10.3)

1,854

(9.9)

1,679

(10.9)

3,959

(10.5)

13,627

(10.2)

2002

1,788

(9.9)

3,604

(10.1)

768

(9.7)

1,927

(10.3)

1,627

(10.6)

3,822

(10.1)

13,536

(10.1)

2003

1,861

(10.3)

3,678

(10.3)

745

(9.4)

1,827

(9.8)

1,565

(10.2)

3,538

(9.3)

13,214

(9.9)

2004

1,793

(9.9)

3,732

(10.4)

717

(9.1)

1,777

(9.5)

1,472

(9.6)

3,514

(9.3)

13,005

(9.7)

2005

1,920

(10.6)

3,813

(10.6)

730

(9.2)

1,820

(9.7)

1,375

(9.0)

3,390

(9.0)

13,048

(9.8)

2006

1,871

(10.3)

3,887

(10.8)

722

(9.1)

1,740

(9.3)

1,369

(8.9)

3,264

(8.6)

12,853

(9.6)

2007

1,883

(10.4)

4,011

(11.2)

649

(8.2)

1,727

(9.2)

1,286

(8.4)

3,366

(8.9)

12,922

(9.7)

  1. †Based on patients diagnosed between 2003 and 2007.